Clinical Trial Update: Effect of Hemp-CBD on Patients With CIPN [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effect of hemp-derived CBD on chemotherapy-induced peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Peripheral Neuropathy
• Colorectal Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Uterine Cancer

Drugs mentioned

• Hemp-CBD (cannabidiol (CBD) from hemp)

Snippet

Sponsor: Main Line Health | Conditions: Chemotherapy-induced Peripheral Neuropathy, Colorectal Cancer Stage II | Phase 2 | Status: UNKNOWN